Spain· ES:1171178003
XELJANZ 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing tofacitinib, registered in Spain by Pfizer Europe Ma Eeig.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- tofacitinib
- Manufacturer
- Pfizer Europe Ma Eeig
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tofacitinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatestofacitinibZydus Lifesciences Limited
- CzechiaTOFACITINIB STADASTADA Arzneimittel AG, Bad Vilbel
- SwitzerlandTofacitinib Devatis 5 mg, FilmtablettenDevatis AG
- FinlandTofacitinib DevatisDevatis GmbH
- SwedenTofacitinib Devatis 5 mg Filmdragerad tablettDevatis GmbH
- NetherlandsTofacitinib Accord 5 mg filmomhulde tablettenAccord Healthcare B.V.
- IrelandTofacitinib STADA 5 mg film-coated tabletsStada Arzneimittel AG
- BelgiumTofacitinib EG 5 mgEG
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Tofacitinib Devatis, Tofacitinib Stada
- Bulgaria · Tофацитиниб Devatis
- Denmark · Tofacitinib Accord, Tofacitinib Newbury
- Finland · Tofacitinib Devatis, Tofacitinib Stada
- France · Tofacitinib Stada
- United Kingdom (Northern Ireland) · Tofacitinib Amarox, Tofacitinib Brown & Burk Uk
- Croatia · Tofacitinib Accord, Tofacitinib Stada
- Iceland · Xeljanz
- Liechtenstein · Xeljanz
- Malta · Tofacitinib Stada
- Netherlands · Tofacitinib Devatis, Tofacitinib Stada
- Norway · Tofacitinib Accord, Tofacitinib Devatis
- Portugal · Tofacitinib Bluepharma
- Sweden · Tofacitinib Devatis, Tofacitinib Newbury
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aea53c53-7bd9-41b8-a432-79aa779ce76c GET /v1/drugs/aea53c53-7bd9-41b8-a432-79aa779ce76c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1493294188000}",
"nregistro": "1171178003",
"substance": "tofacitinib"
}See everything about tofacitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.